ArticleNeuro-oncology practice2025
Nutritional strategies in the management of diffuse gliomas: A systematic review.
Article in Neuro-oncology practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Infiltrating gliomas are progressive brain tumors with an invariably fatal prognosis. Nutritional interventions, such as the ketogenic diet (KD) and caloric restriction, have been explored as adjunct therapies. This systematic review assesses the evidence for the efficacy and safety of these dietary strategies in the management of diffuse gliomas. Methods: A systematic search was conducted in PubMed, covering studies up to February 23, 2024. Inclusion criteria were English-language clinical and observational studies that examined the impact of dietary interventions on diffuse glioma outcomes. Studies were evaluated for risk of bias using the Cochrane Risk of Bias 2 (RoB 2) tool and synthesized descriptively due to the heterogeneity of study designs and outcomes. Results: Eighteen studies (2 randomized clinical trials [RCTs] and 16 observational studies) met the inclusion criteria. The RCTs, classified as high-quality evidence, did not demonstrate significant survival benefits from dietary interventions. Observational studies, while supporting the feasibility and safety of these interventions, provided inconsistent evidence regarding their efficacy in improving overall survival (OS) or progression-free survival (PFS). Methodological limitations, including small sample sizes, variability in dietary adherence, and patient heterogeneity, were common across studies. Discussion: The evidence suggests that while dietary interventions like KD and caloric restriction are generally safe and feasible for diffuse glioma patients, their efficacy in improving survival outcomes remains inconclusive. Limitations such as small sample sizes and variability in adherence underscore the need for larger, well-designed trials to evaluate the clinical benefits of these interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.